Anika Therapeutics Stock Price (NASDAQ:ANIK)

Add to My Stocks
$40.98 $0.04 (0.1%) ANIK stock closing price Sep 17, 2018 (Closing)
Prev Close* : $40.94
Market Cap:
$597.05M
Day Low: $40.8
52 Week Low: $28.54
Open: $41.02
Volume: -
Day High: $41.24
52 Week High: $69.81
Dividend:
0.00

Latest Stock Market News

Latest Articles

Anika Therapeutics News - From Partners

New Strong Sell Stocks for April 16th   by Zacks on Apr 16, 2018
New Strong Sell Stocks for April 2nd   by Zacks on Apr 02, 2018

ANIK Stockcharts

View ANIK PE ratio, PS ratio stocks charts and compare with peers.
ANIK Chart
Note: Compare Anika Therapeutics stock price history with the index and industry peers.

Anika Therapeutics Valuation

PE ratio
(price earnings ratio)
33.87
PS ratio (
price to sales ratio
)
5.54
PB ratio (
price to book ratio
)
2.36

Anika Therapeutics Returns

ROE
(return on equity)
7%

Anika Therapeutics Financial Ratios

Asset Turnover
0.45
Receivables Turnover
4.53
Debt to Equity
0
Dividend Yield
0%

ANIK Industry Peers

Company Price Change (%)
Replimune Group (REPL)18.460.88 (4.55%)
Gtx (GTXI)22.131.99 (8.25%)
Zynex (ZYXI)3.270 (0%)
Histogenics (HSGX)0.540.01 (1.89%)
Zimmer Biomet Holdings (ZBH)129.550.52 (0.4%)
Sanuwave Health (SNWV)0.20.01 (4.76%)
Zimmer Biomet Holdings (ZBH)129.550.52 (0.4%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
AVEO Pharmaceuticals (AVEO)2.880.2 (7.46%)
EYEPOINT PHARMA (EYPT)2.340.14 (6.36%)
MannKind (MNKD)1.710.06 (3.64%)
Osiris Therapeutics (OSIR)11.850.29 (2.51%)
Sinovac Biotech (SVA)7.560.16 (2.16%)
Clovis Oncology (CLVS)32.230.46 (1.45%)
Trevena (TRVN)1.620.02 (1.25%)
Top gainers from Medical-Biomed-Genetics industry
* As of Sep 18, 2018
CompanyPriceChange (%)
Revance (RVNC)23.552.13 (8.3%)
GTx (GTXI)22.131.99 (8.25%)
Bio-Rad Labs (BIO.B)297.66926.58 (8.2%)
Verastem (VSTM)8.240.7 (7.83%)
Intra-Cellular Therapies (ITCI)20.51.68 (7.57%)
Agenus (AGEN)1.830.14 (7.11%)
Uniquire (QURE)38.52.77 (6.71%)
Top losers from Medical-Biomed-Genetics industry
* As of Sep 18, 2018

Anika Therapeutics Inc Stock News - Partner Headlines

Anika Therapeutics Financial Statements

income statement20172016201520142013
Net Sales or Revenues113.42M103.37M92.99M105.59M75.08M
Net Income31.81M32.54M30.75M38.31M20.57M
Total Operating Expense40.32M28.74M23.8M23.21M19.69M
View Anika Therapeutics income statement
balance sheet20172016201520142013
Total Assets282.61M240.24M235.74M193.99M156.04M
Total Liabilities19.12M17.47M24.9M15.89M20.4M
Shareholders Equity263.49M222.77M210.84M178.09M135.63M
View Anika Therapeutics balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-2.35M-15.86M2.95M3.77M-2.92M
Net Cash from (used by) Operating Activities40.81M23.8M39.06M39.97M25.16M
Increase (Decrease) in Prop Plant And Equipment-8.98M-14.01M-9.22M-1.55M-0.25M
View Anika Therapeutics cash flow statement

Anika Therapeutics Stock Message Board

Anika Therapeutics stock price ended the last trading day at $40.98. The total market value as denoted by $597.05M for Anika Therapeutics, is the market value of the company's outstanding shares. Anika Therapeutics valuation can be guaged using various valuation metrics like the price to earnings ratio.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Anika Therapeutics is worth a lot, it will most likely be reflected in an inflated Anika Therapeutics stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume number in Anika Therapeutics stock quote data shows the number of shares traded. For Ex: 76,821 Anika Therapeutics shares were traded as of last trading day, as seen from Anika Therapeutics stock chart. Anika Therapeutics paid 0.00 stock dividends to its shareholders during last quarter. Anika Therapeutics stock price history, gives the entire historical data for ANIK stock.